Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases

表观遗传学 促炎细胞因子 医学 炎症 疾病 衰老 癌症 纤维化 免疫学 生物信息学 癌症研究 生物 病理 内科学 遗传学 基因
作者
Sofia M. Lagoumtzi,Niki Chondrogianni
出处
期刊:Free Radical Biology and Medicine [Elsevier BV]
卷期号:171: 169-190 被引量:247
标识
DOI:10.1016/j.freeradbiomed.2021.05.003
摘要

Cellular senescence is a heterogeneous process guided by genetic, epigenetic and environmental factors, characterizing many types of somatic cells. It has been suggested as an aging hallmark that is believed to contribute to aging and chronic diseases. Senescent cells (SC) exhibit a specific senescence-associated secretory phenotype (SASP), mainly characterized by the production of proinflammatory and matrix-degrading molecules. When SC accumulate, a chronic, systemic, low-grade inflammation, known as inflammaging, is induced. In turn, this chronic immune system activation results in reduced SC clearance thus establishing a vicious circle that fuels inflammaging. SC accumulation represents a causal factor for various age-related pathologies. Targeting of several aging hallmarks has been suggested as a strategy to ameliorate healthspan and possibly lifespan. Consequently, SC and SASP are viewed as potential therapeutic targets either through the selective killing of SC or the selective SASP blockage, through natural or synthetic compounds. These compounds are members of a family of agents called senotherapeutics divided into senolytics and senomorphics. Few of them are already in clinical trials, possibly representing a future treatment of age-related pathologies including diseases such as atherosclerosis, osteoarthritis, osteoporosis, cancer, diabetes, neurodegenerative diseases such as Alzheimer’s disease, cardiovascular diseases, hepatic steatosis, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and age-related macular degeneration. In this review, we present the already identified senolytics and senomorphics focusing on their redox-sensitive properties. We describe the studies that revealed their effects on cellular senescence and enabled their nomination as novel anti-aging agents. We refer to the senolytics that are already in clinical trials and we present various adverse effects exhibited by senotherapeutics so far. Finally, we discuss aspects of the senotherapeutics that need improvement and we suggest the design of future senotherapeutics to target specific redox-regulated signaling pathways implicated either in the regulation of SASP or in the elimination of SC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
1秒前
1秒前
蓝桉完成签到,获得积分10
1秒前
2秒前
2秒前
霁月发布了新的文献求助10
2秒前
2秒前
aajhajkahna的应助被linn采纳,获得10
2秒前
所所的应助被喷火战斗鸡采纳,获得10
2秒前
3秒前
Owen的应助被美年达采纳,获得10
3秒前
4秒前
SYX发布了新的文献求助10
4秒前
syvshc的应助被mmyhn采纳,获得10
4秒前
Li_216完成签到,获得积分10
4秒前
4秒前
茉云完成签到,获得积分10
4秒前
哈哈笑啊完成签到,获得积分20
5秒前
霁月发布了新的文献求助10
5秒前
可爱的函函的应助被Echo采纳,获得10
5秒前
霁月发布了新的文献求助10
5秒前
霁月发布了新的文献求助10
5秒前
霁月发布了新的文献求助10
5秒前
可持续发展中完成签到,获得积分10
5秒前
李健的应助被hhh__hhh采纳,获得10
7秒前
7秒前
树有麋鹿完成签到 ,获得积分10
7秒前
方南茜完成签到,获得积分10
8秒前
勤奋的若发布了新的文献求助10
8秒前
林好事发布了新的文献求助10
8秒前
8秒前
Dnil完成签到,获得积分10
8秒前
syvshc的应助被于某人采纳,获得10
9秒前
9秒前
苗苗发布了新的文献求助10
10秒前
科研通AI2S的应助被欢喜的芷文采纳,获得10
10秒前
堇笙vv完成签到,获得积分10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178280
求助须知:如何正确求助?哪些是违规求助? 9569046
关于积分的说明 21802436
捐赠科研通 7773138
什么是DOI,文献DOI怎么找? 3432735
关于科研通互助平台的介绍 2556770
邀请新用户注册赠送积分活动 2478274